CD24 and prostate cancer: In our study, we have confirmed the overexpression of CD24 in canine prostate cancer—similar to human PC and the mouse model with PC–and though the correlation between CD24 expression and prognosis was not statistically significant, we found a tendency to lower survival rates in canine patients with positive CD24 expression.